Psoriasis can feel all-consuming, but the right strategies and support can make life more manageable when you're going ...

Johnson & Johnson said on Friday its experimental psoriasis drug met the main goal of a late-stage study, as the once-daily ...

Researchers reviewed a host of studies investigating diet plans in an effort to guide evidence-based recommendations for ...

Thomas Fuller / SOPA Images / LightRocket via Getty Images Charles River Laboratories made changes in its board and announced a strategic review as it faced pressure from Elliott Investment ...

The impact of psoriasis on quality of life goes beyond clinical measures, such as psoriasis area severity index (PASI) and ...

7. Dr. Steed’s team has disagreed with this characterization of her review. The board told her she “met or exceeded expectations” for “financial management” during her March 1 ...

Amid a chaotic biopharma ecosystem and declining revenues, Charles River Laboratories is initiating a strategic review and shaking up its board. The CRO’s board will “conduct a comprehensive ...

Elliott's Global Head of Engagement Steven Barg will join the board along with three other ... Charles River will initiate a comprehensive strategic review of its business to help push the stock ...

Once-daily 0.3% topical roflumilast foam significantly reduced severity in patients with psoriasis of the scalp and body over 8 weeks, with a favorable safety profile. “Use of roflumilast foam ...

This eliminates clumps of extra cable between pedals that are packed in tight, and frees up spare cable to run above, below, and around your board to reach pedals in all places. The cable worked ...

Entries to the David Roche Gallery’s inaugural Best in Show 2025: Australian Photographic Dog Prize competition will close on 19 May 2025. David Roche with a Kerry Blue terrier, 19502. (Supplied image ...